See how top analysts and institutions rate APH — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| BofA Securities | Upgrade | Neutral → Buy | $150 | 2025-10-15 |
| Barclays | Initiated | Equal Weight | $120 | 2025-10-08 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 9 | 6 | 0 | 0 |
| October 2025 | 2 | 8 | 5 | 0 | 1 |
| September 2025 | 2 | 8 | 6 | 0 | 1 |
| July 2025 | 2 | 8 | 7 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for APH, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
